Investing.com — Synthomer stock is falling 9.2% to trade at 104.05p during today’s session, reversing sharply from an opening print of 122p that briefly pushed the shares to within a fraction of their 52-week high of 123.95p.

The catalyst was the company’s AGM trading statement, released this morning alongside its Annual General Meeting, which confirmed strong first-half 2026 trading — with volume, revenue, EBITDA, and EBITDA margin all recording meaningful year-on-year progress — driven by accelerated momentum in Q2 as the U.S.-Iran conflict disrupted the supply chains of Asian competitors, allowing Synthomer to capture higher volumes and pass through elevated raw material and energy costs to customers.

Despite the operationally upbeat update, the market’s reaction reflects a classic “sell the news” dynamic: the shares had already surged dramatically from a 52-week low of 16.7p, and the strong trading backdrop appeared largely anticipated.

The company also noted the ongoing unwind of a £50m receivables purchasing arrangement and flagged continued geopolitical uncertainty as risks to the outlook.

The June 19 announcement that Synthomer’s Acrylate Monomers business would be sold to Mutares with no upfront cash consideration — only a contingent earn-out of up to €12m over three years — may have further tempered enthusiasm about near-term deleveraging progress.

The broader UK market context has added modest pressure, with the FTSE 100 navigating a period of political uncertainty following reported leadership pressures on Prime Minister Keir Starmer, alongside mixed macro signals including above-forecast public sector borrowing in May.

Specialty chemicals peers operating in similar polymer and coatings markets face comparable headwinds from geopolitical volatility, meaning Synthomer’s sharp intraday reversal is not entirely isolated from sector-wide caution.

Taken together, a technically overextended share price meeting a “buy the rumour, sell the fact” moment — compounded by nuanced concerns around cash flow and divestment terms — explains today’s outsized decline.

The company’s fundamentals have materially improved, with interim results scheduled for August 4, 2026, likely to serve as the next key catalyst for a reassessment of fair value.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.